Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2022-01, Vol.97 (1), p.E7-E10
Hauptverfasser:	King, Amber C., Weis, Taylor M., Derkach, Andriy, Ball, Somedeb, Pandey, Manu, Mauro, Michael J., Goldberg, Aaron D., Stahl, Maximilian, Famulare, Christopher, Tallman, Martin S., Wang, Eunice S., Kuykendall, Andrew T., Rampal, Raajit K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - adverse effects Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Female Hematology Humans Male Middle Aged Myeloproliferative Disorders - drug therapy Retrospective Studies Sulfonamides - adverse effects Sulfonamides - therapeutic use Toxicity Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!